Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,668 public trials 1,508 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Active, Not Recruiting

D9319C00001- 1L OC Mono Global RCT

NCT04884360

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Santiago, Chile
  • Research Site Santiago, Chile
  • Research Site Temuco, Chile
  • Research Site Temuco, Chile
View all 89 locations
View Trial Details
Active, Not Recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation

NCT04969887

Conditions
Advanced Biliary Tract Cancer, Female Reproductive System Neoplasm, Female Urogenital Diseases, +14 more
Locations
  • Border Medical Oncology Unit Albury, New South Wales, Australia
  • Orange Health Service Orange, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

NCT06240598

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

NCT05601752

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Augusta University Augusta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details

Related conditions